Montreal, Canada – November, 8, 2005 - PainCeptor Pharma Corp., a drug discovery and development company focused on novel therapeutic targets for the treatment of chronic and acute pain, today announced that it has met its key development milestones and has selected pre-clinical development lead candidates for its two most advanced programs.
